149 related articles for article (PubMed ID: 1824651)
1. Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up.
Talseth T; Westlie L; Daae L
Am Heart J; 1991 Jan; 121(1 Pt 2):280-5. PubMed ID: 1824651
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
Talseth T; Westlie L; Daae L; Vatle S
Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
[TBL] [Abstract][Full Text] [Related]
3. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
Frick MH; Cox DA; Himanen P; Huttunen M; Pitkäjärvi T; Pörsti P; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
Am J Cardiol; 1987 May; 59(14):61G-67G. PubMed ID: 2884854
[TBL] [Abstract][Full Text] [Related]
4. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
Talseth T; Westlie L; Daae L
J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
[TBL] [Abstract][Full Text] [Related]
5. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
Nash DT; Schonfeld G; Reeves RL; Black H; Weidler DJ
Am J Cardiol; 1987 May; 59(14):87G-90G. PubMed ID: 2884859
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of doxazosin versus atenolol in mild-to-moderate hypertension.
Giorgi G; Legramante JM; Fioravanti G; Paies G; Legramante A
Am Heart J; 1988 Dec; 116(6 Pt 2):1801-5. PubMed ID: 2904754
[TBL] [Abstract][Full Text] [Related]
7. Doxazosin versus atenolol: a randomized comparison of calculated coronary heart disease risk reduction.
Mazzola C; Guerrasio E
Am Heart J; 1988 Dec; 116(6 Pt 2):1797-801. PubMed ID: 2904753
[TBL] [Abstract][Full Text] [Related]
8. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.
Frick MH; Halttunen P; Himanen P; Huttunen M; Pörsti P; Pitkäjärvi T; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):55S-62S. PubMed ID: 2939868
[TBL] [Abstract][Full Text] [Related]
9. A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk.
Daae LN; Westlie L
Blood Press; 1998 Jan; 7(1):39-45. PubMed ID: 9551876
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Ott P; Storm TL; Krusell LR; Jensen H; Badskjaer J; Faergeman O
Am J Cardiol; 1987 May; 59(14):73G-77G. PubMed ID: 2884856
[TBL] [Abstract][Full Text] [Related]
11. Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial.
Searle M; Dathan R; Dean S; Christensen CC; Westheim A
Eur J Clin Pharmacol; 1990; 39(3):299-300. PubMed ID: 2147909
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of doxazosin in the treatment of patients with mild or moderate essential hypertension and elevated levels of cholesterol.
Taylor SH
Am Heart J; 1991 Jan; 121(1 Pt 2):362-6. PubMed ID: 1824662
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
Talseth T; Westlie L; Daae LN
J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
[TBL] [Abstract][Full Text] [Related]
14. Long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Lijnen P; Fagard R; Staessen J; Lissens W; Amery A
J Cardiovasc Pharmacol; 1989 Aug; 14(2):319-25. PubMed ID: 2476608
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
Lijnen P; Fagard R; Staessen J; Amery A
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
[TBL] [Abstract][Full Text] [Related]
17. Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group.
Carruthers G; Dessain P; Fodor G; Newman C; Palmer W; Sim D
Am J Cardiol; 1993 Mar; 71(7):575-81. PubMed ID: 8438744
[TBL] [Abstract][Full Text] [Related]
18. Short-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Lijnen P; Fagard R; Staessen J; Amery A
J Cardiovasc Pharmacol; 1988 Oct; 12(4):461-6. PubMed ID: 2465447
[TBL] [Abstract][Full Text] [Related]
19. Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension.
Wessels F
Am Heart J; 1991 Jan; 121(1 Pt 2):299-303. PubMed ID: 1824653
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics and pharmacodynamics of doxazosin compared with atenolol during long-term double-blind treatment.
Faulkner JK; Himanen P; Karjalainen U; Saraste M
Eur J Clin Pharmacol; 1987; 31(6):685-93. PubMed ID: 2951261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]